SEC Comment Letter for NEKTAR THERAPEUTICS (NKTR) (CIK 0000906709) (NKTR) — Feb 23, 2009
NEKTAR THERAPEUTICS (NKTR) (CIK 0000906709)
Date: Feb. 23, 2009 · CIK: 0000906709 · Accession: 0000000000-09-009436
AI Filing Summary & Sentiment
File numbers found in text: 000-24006
Letter
Via Facsimile and U.S. Mail Mail Stop 6010 February 23, 2009 Mr. Gil M. Labrucherie Senior Vice President, Gene ral Counsel and Secretary Nektar Therapeutics 201 Industrial Road San Carlos, CA 94070 Re: Nektar Therapeutics Form 10-K for the Year Ended December 31, 2007 Filed February 29, 2008 File No. 000-24006
Dear Mr. Labrucherie: We have completed our review of your annual report on Form 10-K and have no further comments at this time.
Sincerely,
J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r
Show Raw Text
Via Facsimile and U.S. Mail Mail Stop 6010 February 23, 2009 Mr. Gil M. Labrucherie Senior Vice President, Gene ral Counsel and Secretary
Nektar Therapeutics 201 Industrial Road San Carlos, CA 94070
Re: Nektar Therapeutics
Form 10-K for the Year Ended December 31, 2007 Filed February 29, 2008 File No. 000-24006
Dear Mr. Labrucherie: We have completed our review of your annual report on Form 10-K and have no
further comments at this time.
Sincerely,
J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r